文献速递系统性红斑狼疮

系统性红斑狼疮患者缓解率、预测因素及预后获益的系统综述

Prevalence, Predictors, and Prognostic Benefits of Remission Achievement in Patients With Systemic Lupus Erythematosus: A Systematic Review.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-01-11

该系统综述纳入41项研究共17270例成人SLE患者,评估缓解的患病率、预测因素及预后获益。近5年多数研究中42.4-88%患者实现并维持1年缓解,21.1-70%维持至少5年缓解;缓解与较低损伤累积和较好生活质量相关。

要点

  • SLE患者1年缓解率为42.4-88%,至少5年缓解率为21.1-70%。
  • 诊断时年龄较大、基线疾病活动度较低及无主要器官受累与缓解相关。
  • 血清学阳性与缓解呈负相关,缓解(尤其持续缓解)与较低损伤累积和较好生活质量相关。

核心结论

  • 缓解是SLE患者可实现且理想的目标,并与预后获益相关。

研究设计与样本

  • 系统综述,检索PubMed和Embase数据库,纳入报告成人SLE患者缓解患病率、预测因素及预后获益的研究,最终分析41项研究共17270例患者。

主要发现

  • 近5年多数研究中42.4-88%的患者实现并维持1年缓解,21.1-70%的患者维持至少5年缓解。
  • 与缓解相关的因素包括诊断时年龄较大、基线疾病活动度较低及无主要器官受累。
  • 血清学阳性结果与缓解呈负相关。
  • 实现缓解(尤其持续缓解)与较低的损伤累积和较好的生活质量相关。

关键数值与推荐

  • 缓解定义尚未达成共识,但临床疾病活动度、血清学活动度、持续时间及治疗被认为是定义缓解状态的关键组成部分。

临床怎么用

  • 临床可将缓解作为SLE治疗目标,并关注诊断时年龄、基线疾病活动度、主要器官受累及血清学状态等预测因素。

局限性

  • 缓解定义尚未达成共识,需进一步开发 and 评估明确的缓解定义、风险分层模型及包含监测频率、治疗调整和停药的全算法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To systematically review and evaluate the prevalence, potential predictors, and prognostic benefits of remission achievement in patients with systemic lupus erythematosus (SLE). METHODS: Studies reporting on the prevalence, predictors, and prognostic benefits of remission in adult patients with SLE were searched and selected from PubMed and Embase databases. Studies were reviewed for relevance and quality. Two reviewers independently assessed the studies and extracted data. RESULTS: Data from 41 studies including 17,270 patients were included and analyzed. Although no consensus has been achieved on the definition of remission, clinical disease activity, serologic activity, duration, and treatment are agreed to be critical components of defining remission status. In most studies published in the recent 5 years, 42.4-88% of patients achieved and maintained the remission status for 1 year, and 21.1-70% did so for at least 5 years. Factors associated with remission included older age at diagnosis, lower baseline disease activity, and absence of major organ involvement, while positive serologic results were shown to be negatively associated with remission. Remission (especially prolonged remission) when achieved, demonstrated an association with lower accrual of damage and better quality of life among patients with SLE. CONCLUSION: Remission is an achievable and desirable target for SLE patients and proven to be associated with prognostic benefits. Further development and assessment of a clear remission definition, a risk stratification model, as well as a full algorithm with frequency of monitoring time points for treatment adjustment and drug withdrawal are required.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Yang Z, Cheng C, Wang Z, et al. Prevalence, Predictors, and Prognostic Benefits of Remission Achievement in Patients With Systemic Lupus Erythematosus: A Systematic Review. Arthritis Care Res (Hoboken). 2022. PMID: 32986933. doi:10.1002/acr.24464

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。